Bristol-Myers Squibb Asked to Lower HIV Drug Prices

Treating HIV is a long, never-ending, and expensive journey, mainly of because the medications needed to temporarily hold the spread of the virus. This is why government officials and HIV/AIDS advocates has asked Bristol-Myers Squibb to have the prices of its HIV-related medication. Weeks ago, Controller John Chiang sent a letter asking BMS to join other pharmaceutical companies that have already reduced the cost

Older Swingers More Prone to Common VDs

Most older Americans have a lot of problems to deal with especially when it comes to their health, but acquiring sexually transmitted disease is far from it. However, some of the over-45 crowd are prone to getting venereal diseases. In a study published in the British Medical Journal, older swingers (who practice mate swapping and group sex) are at high risk for common sexually transmitted infections like chlamyd

Newly-Discovered Antibodies Could Pave the Way for HIV Vaccine

After several years of research, a group of scientists have finally found antibodies that could be the bases for an HIV vaccine. These researchers, representing the National Institute of Allergy and Infectious Diseases, claim they have discovered three human antibodies that can neutralize more than 90 percent of the current HIV-1 strains. Although there were other antibodies discovered prior to this, they often p

HIV Link to Deadly Salmonella

Recent research has discovered a deadly link between HIV and salmonella, providing a new perspective on vaccine development. Salmonella bacteria often causes fatal infections in the bloodstream in people with HIV. Although this risk has been known for over 25 years, it is only now that scientists discover the scientific reason: It is the excess of antibodies, not the deficiency in the immune system, that causes the

Sexually-Active Boys Unaware About HIV and STDs

US-based researchers reported that boys who engaged in high-risk sexual activities receive little to no counseling about HIV and other sexually transmitted diseases. The study was conducted by Dr. Arik Marcell, a pediatrician at John Hopkin Children’s Center, and other colleagues using data from the 1995 National Survey of Adolescent Males and the 2002 National Survey of Family Growth. According to the repo

Early Antibiotic Treatment May Help AIDS Patients

A research has confirmed that the use of an inexpensive and commonly-prescribed antibiotic has dramatically reduced the number of deaths among AIDS patients in Africa.  The drug co-trimoxazole, which is marketed under brand names such as Septrim or Bactrim, is widely used to treat pneumonia as well as ear and urinary tract infections.  It has also been found to be able to treat malaria. The study, which w

Herpes Drug May Slow HIV Progression

New research has revealed that a drug prescribed for patients with herpes can also slow down the progression of HIV-1, preventing the virus from becoming full-blown AIDS.  The effect of the drug, called acyclovir, was studied on almost 3,400 people in Africa who were infected with HIV-1 and herpes simplex virus type 2. According to the study, conducted in the University of Washington and lead by Dr. Jairam Lin

HIV May Age the Brain Prematurely

Researchers at the Washington University School of Medicine have found that individuals who were tested positive for HIV may be prone from premature aging of the brain, either because of the infection itself, the treatment needed to control it, or both. The study involves the use of magnetic resonance imaging scanners to study the brains of 26 HIV+ patients and 25 uninfected subjects.  The researchers have fou

Research Finds HIV Mutations that Causes Drug Resistance

A recent research conducted by chemists at University of California in San Diego and statisticians at Harvard University have developed a new way of tracking down mutations in HIV that can cause drug resistance.  The findings, which was published in the online edition of the Proceedings of the National Academy of Sciences, would allow doctors to customize their prescriptions to particular strains of the virus

Suicide Rate Among HIV Patients Decreases

A study has revealed that suicide rates among HIV patients in Switzerland have decreased by more than half after highly active antiretroviral therapy was introduced in 1996. HIV, or human immunodeficiency virus, is a virus that causes AIDS.  Meanwhile, highly active antiretroviral therapy (otherwise known as HAART) has been associated with an increase among patients’ CD4 white blood cells, indicating an